CEACAM5 and gastric cancer: However, among patients with stage III gastric cancer, RFS was significantly lower in the elevated preoperative CEA cohort than that of normal preoperative CEA cohort (3-year RFS rate, 60.9% vs 74.8%, Log-rank P = 3.5E-04) (Figure 2C).